Fig. 1. Antioxidant activity of MD pharmacopuncture by purification stage. (A) 2,2-diphenyl-1-picrylhydrazyl, (B) 2,2-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid), (C) ferric reducing antioxidant power. Data are expressed as meanĀ±SD of triplicate experiments. Statistically significant differences between bars are indicated with different Greek alphabet characters; same alphabet characters imply no significant difference between bars (p<0.01). SD: standard deviation.
© 2024 J Korean Med Rehabi